A citation-based method for searching scientific literature

Diana S Rosman, Virginia Kaklamani, Boris Pasche. Curr Treat Options Oncol 2007
Times Cited: 15







List of co-cited articles
80 articles co-cited >1



Times Cited
  Times     Co-cited
Similarity


TGFBR1(*)6A and Int7G24A variants of transforming growth factor-beta receptor 1 in Swedish familial and sporadic breast cancer.
B Song, S Margolin, J Skoglund, X Zhou, J Rantala, S Picelli, B Werelius, A Lindblom. Br J Cancer 2007
19
26

Prevalence and penetrance of germline BRCA1 and BRCA2 mutations in a population series of 649 women with ovarian cancer.
H A Risch, J R McLaughlin, D E Cole, B Rosen, L Bradley, E Kwan, E Jack, D J Vesprini, G Kuperstein, J L Abrahamson,[...]. Am J Hum Genet 2001
718
20

Int7G24A variant of transforming growth factor-beta receptor type I is associated with invasive breast cancer.
Taiping Chen, Chad R Jackson, Andrew Link, Michael P Markey, Bruce M Colligan, Larry E Douglass, Jackson O Pemberton, James A Deddens, Jeremy R Graff, Julia H Carter. Clin Cancer Res 2006
36
20

TGFBR1*6A and cancer risk: a meta-analysis of seven case-control studies.
Virginia G Kaklamani, Nanjiang Hou, Yiansong Bian, Jennifer Reich, Kenneth Offit, Loren S Michel, W S Rubinstein, Alfred Rademaker, Boris Pasche. J Clin Oncol 2003
73
20

TbetaR-I(6A) is a candidate tumor susceptibility allele.
B Pasche, P Kolachana, K Nafa, J Satagopan, Y G Chen, R S Lo, D Brener, D Yang, L Kirstein, C Oddoux,[...]. Cancer Res 1999
130
20

TGFbeta in Cancer.
Joan Massagué. Cell 2008
20

Multiple ways of silencing E-cadherin gene expression in lobular carcinoma of the breast.
S Droufakou, V Deshmane, R Roylance, A Hanby, I Tomlinson, I R Hart. Int J Cancer 2001
158
13

Early gastric cancer development in a familial adenomatous polyposis patient.
Shouji Shimoyama, Fumio Aoki, Masaki Kawahara, Naohisa Yahagi, Toru Motoi, Shu Kuramoto, Michio Kaminishi. Dig Dis Sci 2004
12
16

Diffuse type gastric and lobular breast carcinoma in a familial gastric cancer patient with an E-cadherin germline mutation.
G Keller, H Vogelsang, I Becker, J Hutter, K Ott, S Candidus, T Grundei, K F Becker, J Mueller, J R Siewert,[...]. Am J Pathol 1999
210
13

Bilateral prophylactic mastectomy reduces breast cancer risk in BRCA1 and BRCA2 mutation carriers: the PROSE Study Group.
Timothy R Rebbeck, Tara Friebel, Henry T Lynch, Susan L Neuhausen, Laura van 't Veer, Judy E Garber, Gareth R Evans, Steven A Narod, Claudine Isaacs, Ellen Matloff,[...]. J Clin Oncol 2004
706
13


Epigenetic and genetic alterations of APC and CDH1 genes in lobular breast cancer: relationships with abnormal E-cadherin and catenin expression and microsatellite instability.
David Sarrió, Gema Moreno-Bueno, David Hardisson, Carolina Sánchez-Estévez, Mingzhou Guo, James G Herman, Carlos Gamallo, Manel Esteller, José Palacios. Int J Cancer 2003
142
13

Chromoendoscopic surveillance in hereditary diffuse gastric cancer: an alternative to prophylactic gastrectomy?
D Shaw, V Blair, A Framp, P Harawira, M McLeod, P Guilford, S Parry, A Charlton, I Martin. Gut 2005
117
13

E-Cadherin (CDH1) and p53 rather than SMAD4 and Caspase-10 germline mutations contribute to genetic predisposition in Portuguese gastric cancer patients.
Carla Oliveira, Paulo Ferreira, Sérgio Nabais, Luisa Campos, Ana Ferreira, Luís Cirnes, Catarina Castro Alves, Isabel Veiga, Maria Fragoso, Fernando Regateiro,[...]. Eur J Cancer 2004
72
13

Very high risk of cancer in familial Peutz-Jeghers syndrome.
F M Giardiello, J D Brensinger, A C Tersmette, S N Goodman, G M Petersen, S V Booker, M Cruz-Correa, J A Offerhaus. Gastroenterology 2000
795
13

Germline E-cadherin mutations in familial lobular breast cancer.
S Masciari, N Larsson, J Senz, N Boyd, P Kaurah, M J Kandel, L N Harris, H C Pinheiro, A Troussard, P Miron,[...]. J Med Genet 2007
116
13

Founder and recurrent CDH1 mutations in families with hereditary diffuse gastric cancer.
Pardeep Kaurah, Andrée MacMillan, Niki Boyd, Janine Senz, Alessandro De Luca, Nicki Chun, Gianpaolo Suriano, Sonya Zaor, Lori Van Manen, Cathy Gilpin,[...]. JAMA 2007
278
13


CDH1 truncating mutations in the E-cadherin gene: an indication for total gastrectomy to treat hereditary diffuse gastric cancer.
Jeffrey A Norton, Christine M Ham, Jacques Van Dam, R Brooke Jeffrey, Teri A Longacre, David G Huntsman, Nicki Chun, Allison W Kurian, James M Ford. Ann Surg 2007
119
13

E-cadherin is inactivated in a majority of invasive human lobular breast cancers by truncation mutations throughout its extracellular domain.
G Berx, A M Cleton-Jansen, K Strumane, W J de Leeuw, F Nollet, F van Roy, C Cornelisse. Oncogene 1996
366
13


E-cadherin is a tumour/invasion suppressor gene mutated in human lobular breast cancers.
G Berx, A M Cleton-Jansen, F Nollet, W J de Leeuw, M van de Vijver, C Cornelisse, F van Roy. EMBO J 1995
596
13

Germline E-cadherin mutations in hereditary diffuse gastric cancer: assessment of 42 new families and review of genetic screening criteria.
A R Brooks-Wilson, P Kaurah, G Suriano, S Leach, J Senz, N Grehan, Y S N Butterfield, J Jeyes, J Schinas, J Bacani,[...]. J Med Genet 2004
258
13

Role of p120-catenin in cadherin trafficking.
Kanyan Xiao, Rebecca G Oas, Christine M Chiasson, Andrew P Kowalczyk. Biochim Biophys Acta 2007
102
13

Gastric cancer: new genetic developments.
Henry T Lynch, William Grady, Gianpaolo Suriano, David Huntsman. J Surg Oncol 2005
150
13

Differential trends in the intestinal and diffuse types of gastric carcinoma in the United States, 1973-2000: increase in the signet ring cell type.
Donald Earl Henson, Christopher Dittus, Mamoun Younes, Hong Nguyen, Jorge Albores-Saavedra. Arch Pathol Lab Med 2004
245
13

Novel germline CDH1 mutations in hereditary diffuse gastric cancer families.
Bostjan Humar, Tumi Toro, Francesco Graziano, Hansjakob Müller, Zuzana Dobbie, Han Kwang-Yang, Charis Eng, Heather Hampel, Dale Gilbert, Ingrid Winship,[...]. Hum Mutat 2002
54
13


Germline mutations of the E-cadherin(CDH1) and TP53 genes, rather than of RUNX3 and HPP1, contribute to genetic predisposition in German gastric cancer patients.
G Keller, H Vogelsang, I Becker, S Plaschke, K Ott, G Suriano, A R Mateus, R Seruca, K Biedermann, D Huntsman,[...]. J Med Genet 2004
80
13

Characterization of a recurrent germ line mutation of the E-cadherin gene: implications for genetic testing and clinical management.
Gianpaolo Suriano, Sandie Yew, Paulo Ferreira, Janine Senz, Pardeep Kaurah, James M Ford, Teri A Longacre, Jeffrey A Norton, Nicki Chun, Sean Young,[...]. Clin Cancer Res 2005
117
13

Methylation of the CDH1 promoter as the second genetic hit in hereditary diffuse gastric cancer.
W M Grady, J Willis, P J Guilford, A K Dunbier, T T Toro, H Lynch, G Wiesner, K Ferguson, C Eng, J G Park,[...]. Nat Genet 2000
315
13

A randomized clinical trial evaluating tamoxifen in the treatment of patients with node-negative breast cancer who have estrogen-receptor-positive tumors.
B Fisher, J Costantino, C Redmond, R Poisson, D Bowman, J Couture, N V Dimitrov, N Wolmark, D L Wickerham, E R Fisher. N Engl J Med 1989
13



Screening E-cadherin in gastric cancer families reveals germline mutations only in hereditary diffuse gastric cancer kindred.
Carla Oliveira, Maria Cristina Bordin, Nicola Grehan, David Huntsman, Gianpaolo Suriano, José Carlos Machado, Tuula Kiviluoto, Lauri Aaltonen, Charles E Jackson, Raquel Seruca,[...]. Hum Mutat 2002
121
13

[18F]Fluoro-2-deoxy-D-glucose positron emission tomography detects gastric carcinoma in an early stage in an asymptomatic E-cadherin mutation carrier.
Mariette C A van Kouwen, Joost P H Drenth, Wim J G Oyen, Joyce H F M de Bruin, Marjolijn J Ligtenberg, J J Han Bonenkamp, J Han J M van Krieken, Fokko M Nagengast. Clin Cancer Res 2004
31
13

Selective uncoupling of p120(ctn) from E-cadherin disrupts strong adhesion.
M A Thoreson, P Z Anastasiadis, J M Daniel, R C Ireton, M J Wheelock, K R Johnson, D K Hummingbird, A B Reynolds. J Cell Biol 2000
382
13

E-cadherin germline mutations in familial gastric cancer.
P Guilford, J Hopkins, J Harraway, M McLeod, N McLeod, P Harawira, H Taite, R Scoular, A Miller, A E Reeve. Nature 1998
13

Patient-reported symptoms and quality of life during treatment with tamoxifen or raloxifene for breast cancer prevention: the NSABP Study of Tamoxifen and Raloxifene (STAR) P-2 trial.
Stephanie R Land, D Lawrence Wickerham, Joseph P Costantino, Marcie W Ritter, Victor G Vogel, Myoungkeun Lee, Eduardo R Pajon, James L Wade, Shaker Dakhil, James B Lockhart,[...]. JAMA 2006
167
13

Model of the early development of diffuse gastric cancer in E-cadherin mutation carriers and its implications for patient screening.
Fátima Carneiro, David G Huntsman, Thomas C Smyrk, David A Owen, Raquel Seruca, Paul Pharoah, Carlos Caldas, Manuel Sobrinho-Simões. J Pathol 2004
176
13


E-cadherin gene (CDH1) promoter methylation as the second hit in sporadic diffuse gastric carcinoma.
J C Machado, C Oliveira, R Carvalho, P Soares, G Berx, C Caldas, R Seruca, F Carneiro, M Sobrinho-Simöes. Oncogene 2001
203
13

Mutations of the human E-cadherin (CDH1) gene.
G Berx, K F Becker, H Höfler, F van Roy. Hum Mutat 1998
452
13

Epidemiology of gastric cancer.
Katherine D Crew, Alfred I Neugut. World J Gastroenterol 2006
13

E-cadherin gene mutations provide clues to diffuse type gastric carcinomas.
K F Becker, M J Atkinson, U Reich, I Becker, H Nekarda, J R Siewert, H Höfler. Cancer Res 1994
702
13

Recognition and management of hereditary breast cancer syndromes.
Darcy L Thull, Victor G Vogel. Oncologist 2004
63
13

Signaling through beta-catenin and Lef/Tcf.
A Novak, S Dedhar. Cell Mol Life Sci 1999
252
13

Gene-related cancer spectrum in families with hereditary non-polyposis colorectal cancer (HNPCC).
Johanne Geary, Peter Sasieni, Richard Houlston, Louise Izatt, Ros Eeles, Stewart J Payne, Samantha Fisher, Shirley V Hodgson. Fam Cancer 2008
99
13

Infiltrating lobular carcinoma of the breast: tumor characteristics and clinical outcome.
Grazia Arpino, Valerie J Bardou, Gary M Clark, Richard M Elledge. Breast Cancer Res 2004
474
13

Cancer risk estimates for BRCA1 mutation carriers identified in a risk evaluation program.
Marcia S Brose, Timothy R Rebbeck, Kathleen A Calzone, Jill E Stopfer, Katherine L Nathanson, Barbara L Weber. J Natl Cancer Inst 2002
461
13


Co-cited is the co-citation frequency, indicating how many articles cite the article together with the query article. Similarity is the co-citation as percentage of the times cited of the query article or the article in the search results, whichever is the lowest. These numbers are calculated for the last 100 citations when articles are cited more than 100 times.